Kenvue Inc. (FRA:J4D)

Germany flag Germany · Delayed Price · Currency is EUR
13.02
-0.05 (-0.37%)
At close: Oct 20, 2025
-0.37%
Market Cap24.67B
Revenue (ttm)12.92B
Net Income (ttm)1.21B
Shares Outn/a
EPS (ttm)0.63
PE Ratio20.39
Forward PE13.97
Dividend0.75 (5.78%)
Ex-Dividend DateAug 13, 2025
Volumen/a
Average Volume548
Open13.16
Previous Close13.07
Day's Range12.77 - 13.28
52-Week Range11.83 - 23.50
Betan/a
RSI37.29
Earnings DateNov 7, 2025

About Kenvue

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment provides face and body care, hair, sun, and other... [Read more]

Industry Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
Founded 2022
Employees 22,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol J4D
Full Company Profile

Financial Performance

In 2024, Kenvue's revenue was $15.46 billion, an increase of 0.07% compared to the previous year's $15.44 billion. Earnings were $1.03 billion, a decrease of -38.10%.

Financial numbers in USD Financial Statements

News

There is no news available yet.